Location
Israel, Middle East
Cheque size
$10M - $50M
Investment Stage
Seed
Series A
Series B
Focus Areas
Health & Hospital Services
BioTech
Pharmaceuticals
About Investor
Ran Nussbaum serves as Managing Partner and Co-Founder at Pontifax Venture Capital, focusing on investments in Pharmaceuticals, BioTech, and Health & Hospital Services sectors at seed, Series A, and Series B stages with investment ranges between $10.0M and $50.0M. Nussbaum co-founded The Pontifax Group and has served as CEO, leading a healthcare-dedicated venture capital firm that finances pharmaceutical and life sciences companies with more than 65 portfolio companies globally, bringing extensive expertise in bio-pharma investments from his base in Israel.
Previous investments
Adcytherix
32M |2024
LB Pharmaceuticals
75M |2024
Fore Biotherapeutics
57M |2020
Similar Investors
RR
Ran Regev
Israel, Middle East
$100K - $12M
Series A
,Series B
,KS
Kobi Samboursky
Israel, Middle East
$5M - $20M
Seed
,Series A
,AF
Alan Feld
Israel, Middle East
$3M - $10M
Series A
,Series B
,YS
Yaniv Stern
Israel, Middle East
$8M - $12M
Series B
,NA
Nofar Amikam
Israel, Middle East
$5M - $20M
Seed
,Series A
,AA
Abdullah Albesher
Saudi Arabia, Middle East
$2M - $20M
Series B
,Is this Your Profile?
If you have any updates, please fill out our form.